Venture Visionary Partners’s Biogen BIIB Stock Holding History

Venture Visionary Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-102	Closed	-$20.8K	–	570
2022 Q2	$20.8K	Buy	+102	New	+$20.9K	﹤0.01%	1017

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Venture Visionary Partners's BIIB Position: Q3 2022 in Review

Venture Visionary Partners sold out of Biogen (BIIB) in Q3 2022, closing a stake of 102 shares — an estimated $20.8K sold.

Venture Visionary Partners first reported a position in BIIB in Q2 2022 and held it in 1 quarter. The position peaked at $20.8K in Q2 2022. 985 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

Venture Visionary Partners reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
Venture Visionary Partners sold 102 Biogen shares in Q3 2022, an estimated $20.8K.
Venture Visionary Partners first reported a position in Biogen in Q2 2022 and held it in 1 quarter.
Venture Visionary Partners's Biogen position peaked at $20.8K in Q2 2022.
985 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on Venture Visionary Partners's 13F filing for Q3 2022, filed 14 Nov 2022.